Literature DB >> 8808681

Beta2 integrins and ICAM-1 are involved in establishment of the intestinal mucosal T cell compartment.

J W Huleatt1, L Lefrançois.   

Abstract

Development of the mucosal immune system was examined in mice with partial loss of expression of ICAM-1 or CD18. Profound effects on Peyer's patch (PP), lamina propria (LP), and intraepithelial lymphocyte (IEL) T cell populations were observed in mutant mice. Normal expression of CD18 integrins and ICAM-1 was essential for development of the CD8(alpha beta) TCR(alpha beta)LP and IEL compartment and for the generation of normal PP lymphocyte populations. The partial loss of CD8(alpha beta) IEL correlated with the loss of TCR(alpha beta) IEL-mediated lytic activity. The presence of a subset of Thy1+TCR(gamma delta)IEL was also dependent on CD18 integrins and ICAM-1. Both the lytic activity and the expression of CD11c by TCR(gamma delta)IEL were up-regulated in the presence of TCR(alpha beta) T cells. Analysis of bone marrow chimeras demonstrated that a bone marrow-derived ICAM-1+ accessory cell was involved in the generation of some TCR(alpha beta) IEL. These results demonstrated that ICAM-1 and beta2 integrins were required for establishment of a normal intestinal immune system.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8808681     DOI: 10.1016/s1074-7613(00)80321-0

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  16 in total

Review 1.  On the front lines: intraepithelial lymphocytes as primary effectors of intestinal immunity.

Authors:  L Lefrançois; B Fuller; J W Huleatt; S Olson; L Puddington
Journal:  Springer Semin Immunopathol       Date:  1997

2.  CD11a regulates effector CD8 T cell differentiation and central memory development in response to infection with Listeria monocytogenes.

Authors:  Tina O Bose; Quynh-Mai Pham; Evan R Jellison; Juliette Mouries; Christie M Ballantyne; Leo Lefrançois
Journal:  Infect Immun       Date:  2013-01-28       Impact factor: 3.441

Review 3.  γδ T cell migration: Separating trafficking from surveillance behaviors at barrier surfaces.

Authors:  Matthew A Fischer; Natasha B Golovchenko; Karen L Edelblum
Journal:  Immunol Rev       Date:  2020-08-26       Impact factor: 12.988

4.  Lack of IL-7 and IL-15 signaling affects interferon-γ production by, more than survival of, small intestinal intraepithelial memory CD8+ T cells.

Authors:  Dmitry Isakov; Amiran Dzutsev; Jay A Berzofsky; Igor M Belyakov
Journal:  Eur J Immunol       Date:  2011-12       Impact factor: 5.532

5.  Cytolytic and IFN-gamma-producing activities of gamma delta T cells in the mouse intestinal epithelium are T cell receptor-beta-chain dependent.

Authors:  M Kohyama; M Nanno; M Kawaguchi-Miyashita; S Shimada; M Watanabe; T Hibi; S Kaminogawa; H Ishikawa
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

6.  alpha(4)beta(7) independent pathway for CD8(+) T cell-mediated intestinal immunity to rotavirus.

Authors:  N A Kuklin; L Rott; J Darling; J J Campbell; M Franco; N Feng; W Müller; N Wagner; J Altman; E C Butcher; H B Greenberg
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

7.  Isolating Lymphocytes from the Mouse Small Intestinal Immune System.

Authors:  Zhijuan Qiu; Brian S Sheridan
Journal:  J Vis Exp       Date:  2018-02-28       Impact factor: 1.355

8.  Beta2 integrins separate graft-versus-host disease and graft-versus-leukemia effects.

Authors:  Yaming Liang; Chen Liu; Julie Y Djeu; Bin Zhong; Thorsten Peters; Karin Scharffetter-Kochanek; Claudio Anasetti; Xue-Zhong Yu
Journal:  Blood       Date:  2007-10-10       Impact factor: 22.113

9.  Impairment of intestinal intraepithelial lymphocytes in Id2 deficient mice.

Authors:  J-K Kim; M Takeuchi; Y Yokota
Journal:  Gut       Date:  2004-04       Impact factor: 23.059

10.  Intestinal mast cell progenitors require CD49dbeta7 (alpha4beta7 integrin) for tissue-specific homing.

Authors:  M F Gurish; H Tao; J P Abonia; A Arya; D S Friend; C M Parker; K F Austen
Journal:  J Exp Med       Date:  2001-11-05       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.